-+ 0.00%
-+ 0.00%
-+ 0.00%

Nasdaq approved BioSergen's application to delist from the first growth market in Northern Europe, with relevant conditions for the Swedish company.

Zhitongcaijing·09/17/2026 14:33:14
Listen to the news
Nasdaq approved BioSergen's application to delist from the first growth market in Northern Europe, with relevant conditions for the Swedish company.